DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Ottawa Marriott Hotel

2018年10月30日 (火) 午前 7:00 - 2018年10月31日 (水) 午後 3:00

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

Transformation with Collaboration

Session 4: Track A: Regulatory Renewal: More on the Regulatory Changes Implemented and Being Proposed

Session Chair(s)

Lisa  Chartrand

Lisa Chartrand

Director, Regulatory Strategy and Policy

Hoffmann-La Roche Limited, Canada

Following on from Session 3A, given the unprecedented number of regulatory changes being proposed in the last year (and in the next few years to come) which affect various stages of a product’s lifecycle in Canada, this session will summarize, consolidate, clarify, and help to ensure as an industry and consumers that we are all prepared.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Recognize the overarching mandate to the various regulatory changes being implemented and proposed
  • Describe the role of stakeholder input as part of the open consultation process
  • Prepare your organization for the regulatory changes

Speaker(s)

Bruno  Rodrigue

Speaker

Bruno Rodrigue

Health Canada, Canada

Director, Office of Legislation and Regulatory Modernization

Kristen  Beausoleil

Speaker

Kristen Beausoleil

Health Canada, Canada

Manager, Economic Analysis, Office of Legislative and Regulatory Modernization

Julie  Chateauvert, MS

Proposal for the Environmental Risk Assessment of Medicinal Ingredients in Human and Veterinary Drugs

Julie Chateauvert, MS

Health Canada, Canada

Senior Scientific Project Coordination Biologist

Jared  Rhines

Industry Impact Regulatory Changes

Jared Rhines

AKCEA Therapeutics Canada Inc, Canada

General Manager

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。